| Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications G Yogalingam, JJ Hopwood Human mutation 18 (4), 264-281, 2001 | 206 | 2001 |
| Neuraminidase 1 is a negative regulator of lysosomal exocytosis G Yogalingam, EJ Bonten, D van de Vlekkert, H Hu, S Moshiach, ... Developmental cell 15 (1), 74-86, 2008 | 196 | 2008 |
| Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components G Yogalingam, AM Pendergast Journal of Biological Chemistry 283 (51), 35941-35953, 2008 | 127 | 2008 |
| Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia … G Yogalingam, S Hwang, JCB Ferreira, D Mochly-Rosen Journal of Biological Chemistry 288 (26), 18947-18960, 2013 | 121 | 2013 |
| Abl kinases are required for invadopodia formation and chemokine-induced invasion PS Smith-Pearson, EK Greuber, G Yogalingam, AM Pendergast Journal of Biological Chemistry 285 (51), 40201-40211, 2010 | 111 | 2010 |
| Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients U Matte, G Yogalingam, D Brooks, S Leistner, I Schwartz, L Lima, ... Molecular genetics and metabolism 78 (1), 37-43, 2003 | 102 | 2003 |
| Feline mucopolysaccharidosis type VI: Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease G Yogalingam, T Litjens, J Bielicki, AC Crawley, V Muller, DS Anson, ... Journal of Biological Chemistry 271 (44), 27259-27265, 1996 | 83 | 1996 |
| Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes. AC Crawley, G Yogalingam, VJ Muller, JJ Hopwood The Journal of clinical investigation 101 (1), 109-119, 1998 | 74 | 1998 |
| Regulation of mitochondrial processes: a target for heart failure SS Palaniyandi, X Qi, G Yogalingam, JCB Ferreira, D Mochly-Rosen Drug Discovery Today: Disease Mechanisms 7 (2), e95-e102, 2010 | 73 | 2010 |
| Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs G Yogalingam, T Pollard, B Gliddon, RD Jolly, JJ Hopwood Genomics 79 (2), 150-153, 2002 | 60 | 2002 |
| Identification and molecular characterization of α‐L‐iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy G Yogalingam, XH Guo, VJ Muller, DA Brooks, PR Clements, ED Kakkis, ... Human mutation 24 (3), 199-207, 2004 | 58 | 2004 |
| Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis EJ Bonten, D Wang, JN Toy, L Mann, A Mignardot, G Yogalingam, ... The FASEB journal 18 (9), 971-973, 2004 | 58 | 2004 |
| Expression and characterization of human recombinant and α-N-actylglucosaminidase B Weber, JJ Hopwood, G Yogalingam Protein expression and purification 21 (2), 251-259, 2001 | 53 | 2001 |
| Clearance of heparan sulfate and attenuation of CNS pathology by intracerebroventricular BMN 250 in Sanfilippo type B mice M Aoyagi-Scharber, D Crippen-Harmon, R Lawrence, J Vincelette, ... Molecular Therapy Methods & Clinical Development 6, 43-53, 2017 | 46 | 2017 |
| Expression and Characterization of Wild Type and Mutant Recombinant Human Sulfamidase: IMPLICATIONS FOR SANFILIPPO (MUCOPOLYSACCHARIDOSIS IIIA) SYNDROME KJ Perkins, S Byers, G Yogalingam, B Weber, JJ Hopwood Journal of Biological Chemistry 274 (52), 37193-37199, 1999 | 44 | 1999 |
| Short-term, high dose enzyme replacement therapy in sialidosis mice D Wang, EJ Bonten, G Yogalingam, L Mann, A d’Azzo Molecular genetics and metabolism 85 (3), 181-189, 2005 | 43 | 2005 |
| Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1 R Meech, G Yogalingam, PI MacKenzie DNA and cell biology 15 (6), 489-494, 1996 | 43 | 1996 |
| Glycosidase active site mutations in human α-L-iduronidase DA Brooks, S Fabrega, LK Hein, EJ Parkinson, P Durand, G Yogalingam, ... Glycobiology 11 (9), 741-750, 2001 | 40 | 2001 |
| Mucopolysaccharidosis type IIIB: characterisation and expression of wild-type and mutant recombinant α-N-acetylglucosaminidase and relationship with Sanfilippo phenotype in an … G Yogalingam, B Weber, J Meehan, J Rogers, JJ Hopwood Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1502 (3), 415-425, 2000 | 39 | 2000 |
| Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis EJ Bonten, G Yogalingam, H Hu, E Gomero, D van de Vlekkert, A d'Azzo Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (10 …, 2013 | 35 | 2013 |
